Oncimmune Germany

Oncimmune Germany is owned by Oncimmune. Oncimmune has a direct presence in 2 countries.

Acquisition, funding and merger involving Oncimmune.

• Freenome has announced the acquisition of Oncimmune  (posted on May 23 2023).

View the org chart displaying its 1 main executives

Most searched biographies at Oncimmune Germany

• Petra Budde, Head of Medical Research

Create your alert
to follow the executive moves at Oncimmune Germany.

Oncimmune has 2,294 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Oncimmune Germany

Social media about Oncimmune Germany

• Oncimmune Germany on Wikipedia, Google News & Yahoo Finance
• Oncimmune Germany on LinkedIn, Twitter & YouTube

Call Oncimmune Germany at +49 231 ...

View the org chart

Register to receive your alert

Report an error